Published online before print June 21, 2004, doi: 10.1161/01.CIR.0000133279.07468.9F
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2004;110:16-21.)
© 2004 American Heart Association, Inc.
Original Articles |
Abdominal Aortic Aneurysm Expansion
Risk Factors and Time Intervals for Surveillance
From the MRC Clinical Trials Unit (A.R.B.), London, UK; the MRC Biostatistics Unit (S.G.T.), Cambridge, UK; the Wolfson Unit for Prevention of Peripheral Vascular Diseases (F.G.R.F.), Public Health Sciences, Edinburgh University Medical School, Edinburgh, UK; and the Department of Vascular Surgery (R.M.G., J.T.P.), Imperial College at Charing Cross Hospital, London, UK.
Correspondence to Prof Janet Powell, Department of Vascular Surgery, Imperial College at Charing Cross Hospital, Fulham Palace Rd, London W6 8RF, UK. E-mail j.powell{at}imperial.ac.uk
Received December 8, 2003; de novo received January 26, 2004; accepted March 19, 2004.
Background— Intervention to reduce abdominal aortic aneurysm (AAA) expansion and optimization of screening intervals would improve current surveillance programs. The aim of this study was to characterize AAA growth in a national cohort of patients with AAA both overall and by cardiovascular risk factors.
Methods and Results— In this study, 1743 patients were monitored for changes in AAA diameter by ultrasonography over a mean follow-up of 1.9 years. Mean initial AAA diameter and growth rate were 43 mm (range 28 to 85 mm) and 2.6 mm/year (95% range, –1.0 to 6.1 mm/year), respectively. Baseline diameter was strongly associated with growth, suggesting that AAA growth accelerates as the aneurysm enlarges. AAA growth rate was lower in those with low ankle/brachial pressure index and diabetes but higher for current smokers (all P<0.001). No other factor (including lipids and blood pressure) was associated with AAA growth. Intervals of 36, 24, 12, and 3 months for aneurysms of 35, 40, 45, and 50 mm, respectively, would restrict the probability of breaching the 55-mm limit at rescreening to below 1%.
Conclusions— Annual, or less frequent, surveillance intervals are safe for all AAAs 
45 mm in diameter. Smoking increases AAA growth, but atherosclerosis plays a minor role.
Key Words: aneurysm • aorta • atherosclerosis • smoking
This article has been cited by other articles:
 |
|
 |
|
  M. Schermerhorn A 66-Year-Old Man With an Abdominal Aortic Aneurysm: Review of Screening and Treatment JAMA, November 11, 2009; 302(18): 2015 - 2022. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. M. Tedesco, M. Terashima, F. G. Blankenberg, Z. Levashova, J. M. Spin, M. V. Backer, J. M. Backer, M. Sho, E. Sho, M. V. McConnell, et al. Analysis of In Situ and Ex Vivo Vascular Endothelial Growth Factor Receptor Expression During Experimental Aortic Aneurysm Progression Arterioscler Thromb Vasc Biol, October 1, 2009; 29(10): 1452 - 1457. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S G Thompson, H A Ashton, L Gao, R A P Scott, and on behalf of the Multicentre Aneurysm Screening St Screening men for abdominal aortic aneurysm: 10 year mortality and cost effectiveness results from the randomised Multicentre Aneurysm Screening Study BMJ, June 24, 2009; 338(jun24_2): b2307 - b2307. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. A. Nienaber, I. Akin, R. Erbel, and A. Haverich CHAPTER 31 Diseases of the Aorta and Trauma to the Aorta and the Heart ESC Textbook of Cardiovascular Medicine, January 1, 2009; 2(1): med-9780199566990-chapter - med-9780199566990-chapter. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. H. Criqui, M. J. Alberts, F. G. R. Fowkes, A. T. Hirsch, P. T. O'Gara, J. W. Olin, and for Writing Group 2 Atherosclerotic Peripheral Vascular Disease Symposium II: Screening for Atherosclerotic Vascular Diseases:: Should Nationwide Programs Be Instituted? Circulation, December 16, 2008; 118(25): 2830 - 2836. [Full Text] [PDF]
|
|
|
|
|
|
J. Golledge, P. S. Tsao, R. L. Dalman, and P. E. Norman Circulating Markers of Abdominal Aortic Aneurysm Presence and Progression Circulation, December 2, 2008; 118(23): 2382 - 2392. [Full Text] [PDF]
|
|
|
|
 |
|
 J. S. Lindholt, H. T. Sorensen, J. B. Michel, H. F. Thomsen, and E. W. Henneberg Low-Dose Aspirin May Prevent Growth and Later Surgical Repair of Medium-Sized Abdominal Aortic Aneurysms Vascular and Endovascular Surgery, August 1, 2008; 42(4): 329 - 334. [Abstract] [PDF]
|
|
|
|
 |
|
 T. Tsuruda, J. Kato, K. Hatakeyama, K. Kojima, M. Yano, Y. Yano, K. Nakamura, F. Nakamura-Uchiyama, Y. Matsushima, T. Imamura, et al. Adventitial Mast Cells Contribute to Pathogenesis in the Progression of Abdominal Aortic Aneurysm Circ. Res., June 6, 2008; 102(11): 1368 - 1377. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. T. Baxter, M. C. Terrin, and R. L. Dalman Medical Management of Small Abdominal Aortic Aneurysms Circulation, April 8, 2008; 117(14): 1883 - 1889. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Golledge, M. Karan, C. S. Moran, J. Muller, P. Clancy, A. E. Dear, and P. E. Norman Reduced expansion rate of abdominal aortic aneurysms in patients with diabetes may be related to aberrant monocyte-matrix interactions Eur. Heart J., March 1, 2008; 29(5): 665 - 672. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. S. Freiberg, A. M. Arnold, A. B. Newman, M. S. Edwards, K. L. Kraemer, and L. H. Kuller Abdominal Aortic Aneurysms, Increasing Infrarenal Aortic Diameter, and Risk of Total Mortality and Incident Cardiovascular Disease Events: 10-Year Follow-Up Data From the Cardiovascular Health Study Circulation, February 26, 2008; 117(8): 1010 - 1017. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Mory, J. Hansmann, J.-R. Allenberg, and D. Boeckler Images in vascular medicine: Rapid expansion of an inflammatory abdominal aortic aneurysm Vascular Medicine, November 1, 2007; 12(4): 381 - 382. [PDF]
|
|
|
|
|
|
P.E. Norman and J.T. Powell Abdominal Aortic Aneurysm: The Prognosis in Women Is Worse Than in Men Circulation, June 5, 2007; 115(22): 2865 - 2869. [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Gitlin, D. B. Trivedi, R. Langenbach, and C. D. Loftin Genetic deficiency of cyclooxygenase-2 attenuates abdominal aortic aneurysm formation in mice Cardiovasc Res, January 1, 2007; 73(1): 227 - 236. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Golledge, J. Muller, A. Daugherty, and P. Norman Abdominal Aortic Aneurysm: Pathogenesis and Implications for Management Arterioscler Thromb Vasc Biol, December 1, 2006; 26(12): 2605 - 2613. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Shimizu, R. N. Mitchell, and P. Libby Inflammation and Cellular Immune Responses in Abdominal Aortic Aneurysms Arterioscler Thromb Vasc Biol, May 1, 2006; 26(5): 987 - 994. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. L. King, D. B. Trivedi, J. M. Gitlin, and C. D. Loftin Selective Cyclooxygenase-2 Inhibition With Celecoxib Decreases Angiotensin II-Induced Abdominal Aortic Aneurysm Formation in Mice Arterioscler Thromb Vasc Biol, May 1, 2006; 26(5): 1137 - 1143. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Touat, V. Ollivier, J. Dai, M.-G. Huisse, A. Bezeaud, U. Sebbag, T. Palombi, P. Rossignol, O. Meilhac, M.-C. Guillin, et al. Renewal of Mural Thrombus Releases Plasma Markers and Is Involved in Aortic Abdominal Aneurysm Evolution Am. J. Pathol., March 1, 2006; 168(3): 1022 - 1030. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Erbel and H. Eggebrecht Aortic dimensions and the risk of dissection Heart, January 1, 2006; 92(1): 137 - 142. [Full Text] [PDF]
|
|
|
|
|
|
C. Longo and G. R. Upchurch Jr Abdominal Aortic Aneurysm Screening: Recommendations and Controversies Vascular and Endovascular Surgery, May 1, 2005; 39(3): 213 - 219. [Abstract] [PDF]
|
|
|
|
|
|
E. M. Isselbacher Thoracic and Abdominal Aortic Aneurysms Circulation, February 15, 2005; 111(6): 816 - 828. [Full Text] [PDF]
|
|